Gunma, Japan

Itaru Urakawa

USPTO Granted Patents = 3 



Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2011-2019

where 'Filed Patents' based on already Granted Patents

3 patents (USPTO):

Title: Itaru Urakawa: Innovator in Antibody Development

Introduction

Itaru Urakawa is a notable inventor based in Gunma, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of 3 patents to his name, Urakawa's work focuses on innovative solutions for medical treatments.

Latest Patents

One of Urakawa's latest patents is the Anti FGF23 antibody and a pharmaceutical composition comprising the same. This invention aims to provide an antibody against FGF23, which can serve as a preventive or therapeutic agent. The antibody works by suppressing the action of FGF23, thereby offering potential treatment options for related conditions. The antibody or its functional fragment against human FGF23 is produced by hybridoma C10 (Accession No. FERM BP-10772).

Career Highlights

Throughout his career, Urakawa has worked with prominent companies in the biotechnology sector. He has been associated with Kyowa Hakko Kirin Co., Limited and Kyowa Kirin Co., Ltd., where he has contributed to various research and development projects. His expertise in antibody development has positioned him as a key player in the industry.

Collaborations

Urakawa has collaborated with several professionals in his field, including notable coworkers such as Yuji Yamazaki and Hitoshi Yoshida. These collaborations have further enhanced his research and innovation capabilities.

Conclusion

Itaru Urakawa's contributions to antibody development highlight his role as an influential inventor in the biotechnology sector. His innovative patents and collaborations reflect his commitment to advancing medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…